21586 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins; Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
THERAPEUTIC AGENTS AND USES THEREOF
#2LEAKY JOINT SYNDROME DIAGNOSTICS AND TREATMENTS
#3ANTI-NUCLEOPHOSMIN 1 ANTIBODY AND ANTIBODY CONJUGATE COMBINATION THERAPIES
#4Antibodies to Amyloid Beta
#5GRP78 NANOBODIES
#6Treatment and Prophylaxis of Amyloidosis
#7METHOD FOR DETECTING SOLUBLE OLIGOMERIC AMYLOID BETA
#8COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
#9ANTI-TROP2 ANTIBODIES IN IMMUNOSUPPRESSED SUBJECTS
#10METHODS AND COMPOSITIONS FOR IMAGING AMYLOID DEPOSITS
#11NOVEL PROTEIN SPECIFICALLY BINDING TO CALRETICULIN AND HAVING HUMAN FIBRONECTIN DOMAIN III SCAFFOLD AND USE THEREOF
#12Improved immunoglobulin I
#13RADIOLIGAND BINDING TO ANTI-DLL3 ANTIBODIES FOR PRETARGETED PET IMAGING AND THERAPEUTIC USES THEREOF
#14IMMUNOCONJUGATES FOR TARGETED RADIOISOTOPE THERAPY
#15ANTI-TRANSTHYRETIN ANTIBODIES
#16CALRETICULIN NANOBODIES
#17COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
#18CYSTEINE LINKED NANOBODY DIMERS
#19COMPOUNDS AND METHODS FOR THE DIAGNOSIS, IMAGING AND TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS
#20FREE PSA ANTIBODIES AS DIAGNOSTICS, PROGNOSTICS AND THERAPEUTICS FOR PROSTATE CANCER
#21METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS
#22ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF
#23CD33 ANTIBODIES AND METHODS OF USING THE SAME TO TREAT CANCER
#24THERAPEUTIC AGENTS AND USES THEREOF
#25COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
#26COMPOSITIONS AND METHODS FOR DIAGNOSIS OF CARDIOVASCULAR DISEASE
#27METHOD FOR DETECTING SOLUBLE OLIGOMERIC AMYLOID BETA
#28Anti-transthyretin antibodies
#29Antibody Molecules and Peptide Delivery Systems for Use in Alzheimer's Disease and Related Disorders
#30COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
#31COMPOSITION AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH NEURITE DEGENERATION
#32Conjugated biological molecules, pharmaceutical compositions and methods
#33Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide
#34Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide
#35Compositions comprising cyclic peptides derived from an A-beta peptide
#36Treatment and Prophylaxis of Amyloidosis
#37Cancer Treatment Methods Using Thermotherapy And/Or Enhanced Immunotherapy
#38Antibodies to centrin-1, methods of making, and uses thereof
#39Anti-C3d antibody conjugates and methods of detecting complement activation
#40Humanized antibodies that recognize alpha-synuclein
#41Antibodies and Vaccines for Use in Therapeutic and Diagnostic Methods for Alpha-Synuclein-Related Disorders
#42Humanized antibodies binding to amyloid-beta (A-beta)
#43THERAPEUTIC AGENTS AND USES THEREOF
#44Anti-transthyretin antibodies
#45TDP-43 specific binding molecules
#46Methods and compositions for imaging amyloid deposits
#47Free PSA antibodies as diagnostics, prognostics and therapeutics for prostate cancer
#48ANTIGEN ASSOCIATED WITH RHEUMATOID ARTHRITIS
#49Peptide-Mediated Non-Covalent Delivery of Active Agents Across the Blood-Brain Barrier
#50Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
#51COMPOSITION AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH NEURITE DEGENERATION
#52METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS
#53Light-Emitting Versions of the Monoclonal Antibody to C3D (MAB 3D29) for Imaging
#54METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS
#55Humanized antibodies that recognize alpha-synuclein
#56Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#57COMPOSITIONS AND METHODS FOR THE DETECTION DIAGNOSIS AND THERAPY OF HEMATOLOGICAL MALIGNANCIES
#58Anti-transthyretin antibodies
#59TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
#60Reducing memory loss in mammals suffering from Alzheimer's disease
#61Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#62C-TERMINAL EPITOPES IN AMYLOID BETA AND CONFORMATIONALLY-SELECTIVE ANTIBODIES THERETO
#63PLEXIN D1 AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY
#64Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#65DNA molecules encoding antibodies to tau and methods of making thereof
#66Antibodies for treatment and diagnosis
#67Conjugated biological molecules, pharmaceutical compositions and methods
#68Methods of treating Alzheimer's disease
#69COMPOSITIONS AND METHODS FOR THE DETECTION DIAGNOSIS AND THERAPY OF HEMATOLOGICAL MALIGNANCIES
#70Humanized antibodies that recognize alpha-synuclein
#71Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders
#72Cysteine linked nanobody dimers
#73Antigen associated with rheumatoid arthritis
#74Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging
#75Method of providing disease-specific binding molecules and targets
#76METHOD FOR DETECTING SOLUBLE OLIGOMERIC AMYLOID BETA
#77Antigens associated with endometriosis, psoriatic arthritis and psoriasis
#78Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
#79TDP-43 specific binding molecules
#80Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
#81Peptide-mediated non-covalent delivery of active agents across the blood-brain barrier
#82Dock-and-Lock (DNL) Complexes for Therapeutic and Diagnostic Use
#83Anti-transthyretin antibodies
#84Detection of Early-Stage Pancreatic Adenocarcinoma
#85COMPOSITIONS AND METHODS FOR THE DETECTION DIAGNOSIS AND THERAPY OF HEMATOLOGICAL MALIGNANCIES
#86Use of VHH antibodies for the preparation of peptide vectors for delivering a substance of interest and their applications
#87Antigen associated with lung cancers and lymphomas
#88Camelid single-domain antibody directed against amyloid beta and methods for producing conjugates thereof
#89Isolated monoclonal anti-repulsive guidance molecule A antibodies and uses thereof
#90Reducing memory loss in mammals suffering from alzheimer's disease
#91Plexin D1 as a target for tumor diagnosis and therapy
#92Method of providing disease-specific binding molecules and targets
#93ANTI-TENASCIN-C A2 ANTIBODIES AND METHODS OF USE
#94ANTIBODIES RECOGNIZING MEDIN
#95Humanized antibodies that recognize alpha-synuclein
#96Radiopharmaceutical solutions with advantageous properties
#97AMYLOID BETA-DERIVED DIFFUSIBLE LIGANDS (ADDLS), ADDL-SURROGATES, ADDL-BINDING MOLECULES AND USES THEREOF
#98Antibodies and Vaccines for Use in Therapeutic and Diagnostic Methods for Alpha-Synuclein-Related Disorders
#99Antigen associated with the neovasculature of tumour metastases
#100Breast Endothelial Cell Expression Patterns
#101A METHOD OF REDUCING BRAIN AMYLOID PLAQUES USING ANTI-AB ANTIBODIES
#102Radiolabelled antibody and uses thereof
#103Treatment of acute myeloid leukemia and myelodysplastic syndromes
#104Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other α-synucleinopathies
#105Neo antibodies for diagnostic imaging of tissue injury
#106Antibodies that bind to repulsive guidance molecule A (RGMA)
#107Human Antibodies and Specific Binding Sequences Thereof for use in Stroke and Ischemia or Ischemic Conditions
#108COMPOSITIONS AND METHODS FOR THE DETECTION DIAGNOSIS AND THERAPY OF HEMATOLOGICAL MALIGNANCIES
#109Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
#110FREE PSA ANTIBODIES AS DIAGNOSTICS, PROGNOSTICS AND THERAPEUTICS FOR PROSTATE CANCER
#111Therapeutic agents and uses thereof
#112TDP-43 specific binding molecules
#113TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
#114Neoantibodies for diagnosing tissue injury
#115Antigen associated with the neovasculature of tumour metastases
#116Method of providing disease-specific binding molecules and targets
#117MAPPING IN VIVO EOSINOPHIL ACTIVATION IN EOSINOPHILIC ESOPHAGITIS
#118Antigen associated with the neovasculature of tumour metastases
#119TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
#120Plexin D1 as a target for tumor diagnosis and therapy
#121Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other α-synucleinopathies
#122COMPOSITIONS AND METHODS FOR TREATING DISEASES OF PROTEIN AGGREGATION INVOLVING IC3B DEPOSITION
#123Antigens Associated with Inflammatory Bowel Disease Including Ulcerative Colitis
#124Antigen associated with rheumatoid arthritis
#125Detection of amyloid deposits using anti-amyloid antibodies
#126PEPTIDE-MEDIATED NON-COVALENT DELIVERY OF ACTIVE AGENTS ACROSS THE BLOOD-BRAIN BARRIER
#127Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
#128Anti-amyloid antibodies
#129Anti-tenascin-C A2 antibodies and methods of use
#130METHODS FOR INCREASING EFFICACY OF RADIOIMMUNOTHERAPY OF MELANOMA
#131Breast endothelial cell expression patterns
#132Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
#133Antigens associated with endometriosis, psoriatic arthritis and psoriasis
#134IN VIVO IMAGING METHOD
#135Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
#136TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
#137Chimeric, humanized, or human antibody 2A4
#138ANTI-TENASCIN MONOCLONAL ANTIBODY THERAPY FOR LYMPHOMA
#139Detection of early-stage pancreatic adenocarcinoma
#140METHOD FOR ISOLATING NEURAL CELLS USING TENASCIN-R COMPOUNDS
#141Use of radioactively labelled molecule specifically binding to ED-B fibronection in a method of treatment of Hodgkin lymphoma
#142METHOD OF TREATING IMMUNE DISEASE USING B-CELL ANTIBODIES
#143Methods of identifying agents that ameliorate or modulate effects of PRO1328 gene disruptions
#144Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
#145Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders
#146Treatment and prophylaxis of amyloidosis
#147COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#148Antibodies that specifically bind to GMAD
#149Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
#150Antigen associated with rheumatoid arthritis
#151Antigen associated with the neovasculature of tumour metastases
#152Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
#153PLEXIN D1 AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY
#154DIAGNOSIS AND TREATMENT OF CANCER BY USING ANTI-PRG-3 ANTIBODY
#155Human monoclonal antibodies that bind human insulin like growth factors and their use
#156Novel gene disruptions, compositions and methods relating thereto
#157VHH antibodies used as peptide vectors for delivering a substance of interest
#158Treatment for central nervous system disorders
#159Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
#160Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
#161IMMUNOTHERAPY OF B CELL MALIGNANCIES AND AUTOIMMUNE DISEASES USING UNCONJUGATED ANTIBODIES AND CONJUGATED ANTIBODIES AND ANTIBODY COMBINATIONS AND FUSION PROTEINS
#162ED-B FIBRONECTIN AS STRATIFICATION MARKER FOR ANTI-TUMOR DRUGS
#163Chimeric, humanized, or human antibody 2A4
#164COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#165Methods of perispinal extrathecal administration of large molecules for diagnostic use in mammals
#166Breast Endothelial Cell Expression Patterns
#167Combination of an anti ED-B fibronectin domain antibody and gemcitabine
#168METHODS AND APPARATUS FOR IMAGING AGENTS FOR DISEASE DETECTION
#169Cancerous disease modifying antibodies
#170Combination of an anti ED-B fibronectin domain antibody and an anti-EGFR-antibody
#171Blood Clot-Targeted Nanoparticles
#172Biological materials and methods useful in the diagnosis and treatment of diseases
#173Alpha-fetoprotein Immu31 antibodies and fusion proteins
#174Anti-TAT188 antibodies
#175Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
#176Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis
#177Breast endothelial cell expression patterns
#178Composition and method for modulating vasculogenesis for angiogenesis
#179MULTIFUNCTIONAL CORE FOR MOLECULAR IMAGING AND TARGETED DELIVERY OF MACROMOLECULES AND DRUGS
#180Methods and therapies for treating inflammatory conditions with exposed collagen
#181Immunotherapeutic method of treating neoplastic conditions
#182Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis
#183Compositions and methods for the detection diagnosis and therapy of hematological malignancies
#184Method of affecting a function of or ablating a non-malignant cell
#185Selective targeting of tumor vasculature using antibody molecules
#186Biological materials and methods useful in the diagnosis and treatment of diseases
#187Binding molecules for the extra-domain B of fibronectin for detection of arteriosclerotic plaque
#188Antibody compositions for the diagnosis and treatment of tumor
#189Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
#190Antibodies that specifically bind to GMAD
#191Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof